Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):465-7. doi: 10.1586/egh.09.41.
No abstract available

Publication types

  • Editorial
  • Portrait

MeSH terms

  • Carcinoma, Hepatocellular / etiology*
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / physiopathology
  • Female
  • Hepatitis C, Chronic / complications*
  • Humans
  • Hyperinsulinism / complications*
  • Hyperinsulinism / drug therapy
  • Hyperinsulinism / physiopathology
  • Hypoglycemic Agents / adverse effects
  • Insulin / adverse effects
  • Insulin Resistance
  • Liver Diseases, Alcoholic / complications*
  • Liver Neoplasms / etiology*
  • Male
  • Metformin / adverse effects
  • Odds Ratio
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Sulfonylurea Compounds

Substances

  • Hypoglycemic Agents
  • Insulin
  • Sulfonylurea Compounds
  • Metformin